Significance of an index of insulin resistance on admission in non- diabetic patients with acute coronary syndromes

Heart

Volumn 82, Issue 4, 1999, Pages 443-447

  Stubbs, P J ^a   Alaghband Zadeh, J ^c   Laycock, J F ^e   Collinson, P O ^d   Carter, G D ^c   Noble, M I M ^b  

^a NORTHWICK PARK HOSPITAL   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^d MAYDAY UNIVERSITY HOSPITAL   (United Kingdom)

^e NONE

Author keywords

Glucose; Insulin resistance; Myocardial infarction; Unstable angina

Indexed keywords

ASPARTATE AMINOTRANSFERASE; GLUCOSE; HYDROXYBUTYRATE DEHYDROGENASE; INSULIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; UNSTABLE ANGINA PECTORIS;

EID: 0032853830     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.82.4.443     Document Type: Article

References (21)

1. 1 DeFronzo RA, Tobin JD, Andres R. The glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979;6:E214-23.
2. 2 DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991;14:173-94.
3. 3 McKeigue PM, Shah B, Marmot MG. Relationship of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 1991; i:382-6.
4. 4 Caro JF. Insulin resistance in obese and non-obese man. J Clin Endocrinol Metab 1991;73:691-5.
5. 5 Oswald GA, Smith CCT, Berteridge DJ, et al. Determinants and importance of stress hyperglycacmia in non-diabetic patients with myocardial infarction. BMJ 1986;293;917-22.
6. 6 Duncan MH, Singh BM, Wise PH, et al. A simple measure of insulin resistance. Lancet 1995;346:120-1.
7. 7 Cleland SJ, Petrie JR, Morris AD, et al. FIRI: a fair insulin resistance index? Lancet 1996;347:770.
8. 8 Oliver MF, Opie LH. Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias. Lancet 1994;343: 155-8.
9. 9 Working group on the Establishment of Ischaemic Heart Disease Registers. Report of the fifth working group. WHO, Eur 8201 (5). Copenhagen: World Health Organisation, 1971.
10. 10 Gillum RF, Fortmann SP, Princas RJ. International diagnostic criteria for acute myocardial infarction and acute stroke. Am Heart J 1984;108:155-8.
11. 11 World Health Organisation. Diabetes mellitus. Report of a WHO Study Group. [WHO Technical Report Series.] Geneva: WHO, 1985:727.
12. 12 Collinson PO, Moseley D, Stubbs P, et al. Troponin T for the differential diagnosis of ischaemic myocardial damage. Ann Clin Biochem 1993;30:11-16.
13. 13 Hamm CW, Ravkilde J, Gerhardt W, et al. The prognostic value of serum troponin T in unstable angina. N Engl J Med 1992;327:146-50.
14. 14 Matthews DR, Hosker JP, Rudenski JS, et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-19.
15. 15 Bergman RN, Prager R, Volund A, et al. Equivalence of the insulin sensitivity index in man derived by the minimal model method and euglycaemic glucose clamp. Am J Clin Invest 1987;79:790-800.
16. 16 Yarnell JWG, Patterson CC, Sweetnam PM. Simple measure of insulin resistance. Lancet 1996;346:1108-9.
17. 17 Del Prato S, Pozzilli P. FIRI: fasting or false insulin resistance index? Lancet 1996;347:132.
18. 18 Reaven GM. Role of insulin resistance in human disease (syndrome X): an expanded definition. Annu Rev Med 1993;44:121-31.
19. 19 Malmberg K, Ryden L, Efendic S, et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol 1995;26:57-65.
20. 20 Opic LH. Glucose and the metabolism of ischaemic myocardium. Lancet 1995;345:1520-21.
21. 21 Neely JR, Grotyohann LW. Role of glycolytic products in damage to ischemic myocardium. Dissociation of adenosine triphosphate levels and recovery of function of reperfused ischemic hearts. Circ Res 1984;55:816-24.